Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23598171

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2013 May
First author
Mossé YP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2013 May;14(6):439-40. doi: 10.1016/S1470-2045(13)70123-2.
    note
    Source null
    related pmid
    23598173
    relationship
    Comment in

Authors and identifiers

  1. name
    Mossé YP
    type
    Author
  2. name
    Lim MS
    type
    Author
  3. name
    Voss SD
    type
    Author
  4. name
    Wilner K
    type
    Author
  5. name
    Ruffner K
    type
    Author
  6. name
    Laliberte J
    type
    Author
  7. name
    Rolland D
    type
    Author
  8. name
    Balis FM
    type
    Author
  9. name
    Maris JM
    type
    Author
  10. name
    Weigel BJ
    type
    Author
  11. name
    Ingle AM
    type
    Author
  12. name
    Ahern C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mossé YP
    type
    Author
  2. name
    Lim MS
    type
    Author
  3. name
    Voss SD
    type
    Author
  4. name
    Wilner K
    type
    Author
  5. name
    Ruffner K
    type
    Author
  6. name
    Laliberte J
    type
    Author
  7. name
    Rolland D
    type
    Author
  8. name
    Balis FM
    type
    Author
  9. name
    Maris JM
    type
    Author
  10. name
    Weigel BJ
    type
    Author
  11. name
    Ingle AM
    type
    Author
  12. name
    Ahern C
    type
    Author
bibliography ids
  1. nci-bib-959af91a4f8862438277728b
book metadata
content sha256
b6e03eac4941ee0318ac552edce71bb2c52da774e21bc12cd70c3a51cc8b4d75
document type
citation
dois
  1. 10.1016/S1470-2045(13)70095-0
electronic publication date
display
2013 Apr 16
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23598171
immutable id
pubmed:23598171@b6e03eac4941ee0318ac552edce71bb2c52da774e21bc12cd70c3a51cc8b4d75
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
6
name
The Lancet. Oncology
nlm unique id
100957246
pages
472-80
volume
14
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2013 May;14(6):439-40. doi: 10.1016/S1470-2045(13)70123-2.
    note
    Source null
    related pmid
    23598173
    relationship
    Comment in
outcomes validated
false
pmid
23598171
provenance
batch id
99e008dabc339d38fd44
provider
NCBI PubMed ESummary
record sha256
79db035837ef58d9802019e460b5ddd3e0ed412e4b2643102e911d7249dd26df
response sha256
804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
retrieved at
2026-09-09T23:46:55.094762+00:00
publication date
display
2013 May
precision
month
year
2013
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23598171/
title
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Preserved source evidence · Not medical advice